Archie Bleyer1. 1. St. Charles Health System, Bend, Oregon; Oregon Health & Science University , Portland, Oregon; and University of Texas Medical School at Houston, Texas.
Abstract
PURPOSE: A need to examine survival trends of individual cancers in older adolescents and young adults (AYAs) is prompted by overall survival trends that have indicated a lack of progress in survival improvement for AYAs compared with both younger and older cancer patients. PATIENTS AND METHODS: The most recent Surveillance, Epidemiology and End Results (SEER) data were used to ascertain survival trends of the 24 most frequent cancers in AYAs. RESULTS: Of the 20 types of cancers in 15- to 39-year-olds evaluable for survival rate trends, only eight had evidence for a statistically significant improvement in their age-adjusted 5-year survival rate since 1985. As of 2000-2007, of the 24 most common types of cancer in American AYAs, nine had an age-adjusted 5-year survival rate in excess of 80% and eight had a survival rate below 60%. In 19 of 21 cancers for which a comparison of survival by gender is feasible, AYA males had a worse survival rate than females. Of the 23 types of cancer that are classifiable as distant disease, 13 had 5-year survival rates of less than 30%. CONCLUSION: While some progress has been made, the lack of improvement for some cancers with distant disease is disappointing. Increased survival of AYA cancer patients offers significant societal gains in terms of years of productivity compared to older adults. If the potential long-term economic impact of health in AYAs is considered, the need to improve the survival of AYAs with cancer is obvious.
PURPOSE: A need to examine survival trends of individual cancers in older adolescents and young adults (AYAs) is prompted by overall survival trends that have indicated a lack of progress in survival improvement for AYAs compared with both younger and older cancerpatients. PATIENTS AND METHODS: The most recent Surveillance, Epidemiology and End Results (SEER) data were used to ascertain survival trends of the 24 most frequent cancers in AYAs. RESULTS: Of the 20 types of cancers in 15- to 39-year-olds evaluable for survival rate trends, only eight had evidence for a statistically significant improvement in their age-adjusted 5-year survival rate since 1985. As of 2000-2007, of the 24 most common types of cancer in American AYAs, nine had an age-adjusted 5-year survival rate in excess of 80% and eight had a survival rate below 60%. In 19 of 21 cancers for which a comparison of survival by gender is feasible, AYA males had a worse survival rate than females. Of the 23 types of cancer that are classifiable as distant disease, 13 had 5-year survival rates of less than 30%. CONCLUSION: While some progress has been made, the lack of improvement for some cancers with distant disease is disappointing. Increased survival of AYA cancerpatients offers significant societal gains in terms of years of productivity compared to older adults. If the potential long-term economic impact of health in AYAs is considered, the need to improve the survival of AYAs with cancer is obvious.
Authors: Helen M Parsons; Linda C Harlan; Nita L Seibel; Jennifer L Stevens; Theresa H M Keegan Journal: J Clin Oncol Date: 2011-09-19 Impact factor: 44.544
Authors: Kayla N LaRosa; Marilyn Stern; Courtney Lynn; Janella Hudson; Damon R Reed; Kristine A Donovan; Gwendolyn P Quinn Journal: Support Care Cancer Date: 2019-02-18 Impact factor: 3.603
Authors: Carla J Berg; Robin C Vanderpool; Betelihem Getachew; Jackelyn B Payne; Meghan F Johnson; Yasmeni Sandridge; Jennifer Bierhoff; Lana Le; Rakiyah Johnson; Amber Weber; Akilah Patterson; Sarah Dorvil; Ann Mertens Journal: J Cancer Educ Date: 2020-12 Impact factor: 2.037
Authors: Eugene Suh; Kayla L Stratton; Wendy M Leisenring; Paul C Nathan; Jennifer S Ford; David R Freyer; Jennifer L McNeer; Wendy Stock; Marilyn Stovall; Kevin R Krull; Charles A Sklar; Joseph P Neglia; Gregory T Armstrong; Kevin C Oeffinger; Leslie L Robison; Tara O Henderson Journal: Lancet Oncol Date: 2020-02-14 Impact factor: 41.316
Authors: Jennifer M Rohan; Dennis Drotar; Melissa Alderfer; Crista Wetherington Donewar; Linda Ewing; Ernest R Katz; Anna Muriel Journal: J Pediatr Psychol Date: 2013-12-23